Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
Yan Peng, Wuxuan Mei, Kaidong Ma, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Practical recommendations for using ctDNA in clinical decision making
Stacey A. Cohen, Minetta C. Liu, Alexey Aleshin
Nature (2023) Vol. 619, Iss. 7969, pp. 259-268
Closed Access | Times Cited: 80
Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial
Xiaofeng Chen, Xiang Xu, Danping Wang, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005830-e005830
Open Access | Times Cited: 45
Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer
Vincenza Caputo, Fortunato Ciardiello, Carminia M. Della Corte, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 102-138
Open Access | Times Cited: 37
Longitudinal Tumor-informed Circulating Tumor DNA Status Predicts Disease Upstaging and Poor Prognosis for Patients Undergoing Radical Cystectomy
Reuben Ben‐David, Neeraja Tillu, Shivaram Cumarasamy, et al.
European Urology Oncology (2024) Vol. 7, Iss. 5, pp. 1105-1112
Closed Access | Times Cited: 12
Waiting for the “liquid revolution” in the adjuvant treatment of colon cancer patients: a review of ongoing trials
Veronica Conca, P. Ciracì, Carla Boccaccio, et al.
Cancer Treatment Reviews (2024) Vol. 126, pp. 102735-102735
Open Access | Times Cited: 11
Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis
Anusha Chidharla, Eliot Rapoport, Kriti Agarwal, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10230-10230
Open Access | Times Cited: 21
Liquid biopsy: Cell-free DNA based analysis in breast cancer
Konstantinos Venetis, Giulia Cursano, Carlo Pescia, et al.
The Journal of Liquid Biopsy (2023) Vol. 1, pp. 100002-100002
Open Access | Times Cited: 21
Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area
Denis Horgan, Yosr Hamdi, Jonathan A. Lal, et al.
Healthcare (2023) Vol. 11, Iss. 3, pp. 431-431
Open Access | Times Cited: 20
Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors
Julien Ancel, Valérian Dormoy, Béatrice Nawrocki‐Raby, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Liquid Biopsy in Lung Cancer: Biomarkers for the Management of Recurrence and Metastasis
Vanessa G. P. Souza, Aisling Forder, Liam J. Brockley, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8894-8894
Open Access | Times Cited: 16
Clinical Utility of Tumor-Naïve Presurgical Circulating Tumor DNA Detection in Early-Stage NSCLC
Tae Hee Hong, Soohyun Hwang, Abhijit Dasgupta, et al.
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 11, pp. 1512-1524
Closed Access | Times Cited: 6
Detection of endometrial cancer using tampon-based collection and methylated DNA markers
Jamie N. Bakkum‐Gamez, Mark E. Sherman, Seth W. Slettedahl, et al.
Gynecologic Oncology (2023) Vol. 174, pp. 11-20
Open Access | Times Cited: 13
Association of circulating tumor HPV16DNA levels and quantitative PET parameters in patients with HPV-positive head and neck squamous cell carcinoma
Mitsuaki Tatsumi, Hidenori Tanaka, Yukinori Takenaka, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Integrating Imaging and Circulating Tumor DNA Features for Predicting Patient Outcomes
Mark Jesus M. Magbanua, Wen Li, Laura van ‘t Veer
Cancers (2024) Vol. 16, Iss. 10, pp. 1879-1879
Open Access | Times Cited: 5
Harnessing ctDNA in Advanced Melanoma: A Promising Tool for Informed Clinical Decisions
Rugilė Pikturnienė, Alvydas Česas, Sonata Jarmalaitė, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1197-1197
Open Access | Times Cited: 4
Innovation in Non-Invasive Diagnosis and Disease Monitoring for Meningiomas
B. Korte, Dimitrios Mathios
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4195-4195
Open Access | Times Cited: 4
Utilização de DNA Tumoral Circulante na Análise de Prognóstico de Pacientes com Tumores Malignos Sólidos do Trato Gastrintestinal: Revisão Sistemática
G Abreu, Mariana Albuquerque de Brito, Ana Paula de Souza Ramos
Revista Brasileira de Cancerologia (2025) Vol. 70, Iss. 4
Open Access
Single-tube, Switched Temperature Amplicon Barcoding (STAB-seq) for Multiplex Detection of Rare Mutations in Circulating Tumor DNA.
Tony E. Godfrey, Ekaterina Kintsurashvili, Gordana Rasic, et al.
Journal of Molecular Diagnostics (2025)
Closed Access
ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer
Valentina Glueck, Christoph Grimm, Magdalena Postl, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 786-786
Open Access
Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic review
Edoardogregorio Galli, Giorgio Patelli, Federica Villa, et al.
Cancer Treatment Reviews (2025) Vol. 135, pp. 102908-102908
Open Access
Dynamic Tumor in Situ Fluid Circulating Tumor DNA Postsurgery Effectively Predicts Recurrence and Clinical Benefits for Glioblastomas
Jiubing Zhang, Guanzheng Liu, Dayang Wang, et al.
Neurosurgery (2025)
Closed Access
Liquid biopsies in cancer
Hang Yin, Manjie Zhang, Yu Zhang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
Circulating Tumor DNA in High-Risk Stage II/III Cutaneous Melanoma: A Feasibility Study
Kristen E. Rhodin, Matthew O’Connor, Aaron D. Therien, et al.
Annals of Surgical Oncology (2025)
Closed Access
The Role of Cell-Free DNA in Cancer Treatment Decision Making
András Telekes, Anna Horváth
Cancers (2022) Vol. 14, Iss. 24, pp. 6115-6115
Open Access | Times Cited: 21
Harnessing liquid biopsies: Exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine
Oluwaseun Adebayo Bamodu, Chen‐Chih Chung, Thomas R. Pisanic
The Journal of Liquid Biopsy (2023) Vol. 2, pp. 100126-100126
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top